207 related articles for article (PubMed ID: 24513482)
1. Lipoprotein-associated phospholipase A2 during the hyperacute stage of ischemic and hemorrhagic strokes.
Rosso C; Rosenbaum D; Pires C; Cherfils C; Koujah N; Mestari F; Gillet E; Crozier S; Sahli-Amor M; Samson Y; Bonnefont-Rousselot D; Khani-Bittar R
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e277-82. PubMed ID: 24513482
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase A2 in patients with noncardioembolic ischemic stroke and severe inflammatory reaction.
Cojocaru IM; Cojocaru M; Tănăsescu R; Iliescu I; Dumitrescu L; Burcin C; Gurban CV; Sfrijan F
Rom J Intern Med; 2009; 47(1):61-5. PubMed ID: 19886071
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein phospholipase A2 mass and activity are not associated with the diagnosis of acute brain ischemia.
Tai W; Garcia M; Mlynash M; Kemp S; Albers GW; Olivot JM
Cerebrovasc Dis; 2014; 38(5):324-7. PubMed ID: 25428761
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lipoprotein-associated phospholipase A
Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
[TBL] [Abstract][Full Text] [Related]
5. Relation between lipoprotein-associated phospholipase A
Zhou F; Liu Y; Shi H; Huang Q; Zhou J
Neurol Sci; 2018 Sep; 39(9):1591-1596. PubMed ID: 29938341
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis.
Li D; Wei W; Ran X; Yu J; Li H; Zhao L; Zeng H; Cao Y; Zeng Z; Wan Z
Clin Chim Acta; 2017 Aug; 471():38-45. PubMed ID: 28514697
[TBL] [Abstract][Full Text] [Related]
7. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
8. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke.
Lin J; Zheng H; Cucchiara BL; Li J; Zhao X; Liang X; Wang C; Li H; Mullen MT; Johnston SC; Wang Y; Wang Y;
Neurology; 2015 Nov; 85(18):1585-91. PubMed ID: 26311748
[TBL] [Abstract][Full Text] [Related]
9. Temporal profile and prognostic value of Lp-PLA2 mass and activity in the acute stroke setting.
Delgado P; Chacón P; Penalba A; Pelegrí D; Merino C; Ribó M; Rubiera M; Álvarez-Sabin J; Montaner J
Atherosclerosis; 2012 Feb; 220(2):532-6. PubMed ID: 22153151
[TBL] [Abstract][Full Text] [Related]
10. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
13. Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmö, Sweden.
Persson M; Berglund G; Nelson JJ; Hedblad B
Atherosclerosis; 2008 Sep; 200(1):191-8. PubMed ID: 18201705
[TBL] [Abstract][Full Text] [Related]
14. Statins Therapy Improves Acute Ischemic Stroke in Patients with Cardio-metabolic Disorders Measured by Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): New Focal Point.
Al-Kuraishy HM; Hussien NR; Al-Naimi MS; Al-Gareeb AI; Lugnier C
Neurol India; 2021; 69(6):1637-1644. PubMed ID: 34979662
[TBL] [Abstract][Full Text] [Related]
15. Serum lipoprotein-associated phospholipase A2 as a promising prognostic biomarker in association with 90-day outcome of acute intracerebral hemorrhage.
Bian L; Mao LG; Sun Y; Shen F; Chen JF; Liu Z; Zhou W
Clin Chim Acta; 2019 Aug; 495():429-435. PubMed ID: 31103624
[TBL] [Abstract][Full Text] [Related]
16. Role of lipoprotein-associated phospholipase A2 activity for the prediction of silent brain infarcts in women.
Riba-Llena I; Penalba A; Pelegrí D; Vilar A; Jarca CI; Filomena J; Montaner J; Delgado P;
Atherosclerosis; 2014 Dec; 237(2):811-5. PubMed ID: 25463126
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.
Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J
Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747
[TBL] [Abstract][Full Text] [Related]
18. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis for the relationship between lipoprotein-associated phospholipase A2 and ischemic stroke].
Xia W; Hu Z; Song Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 42(2):208-214. PubMed ID: 28255125
[TBL] [Abstract][Full Text] [Related]
20. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
